DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 3,690.00
+290.00 (8.53%)
Apr 1, 2026, 3:30 PM KST
DK Life Science Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 8,658 | 2,245 | 4,167 | 4,239 | 5,858 |
Depreciation & Amortization | 6,411 | 5,782 | 3,283 | 2,461 | 2,385 |
Loss (Gain) From Sale of Assets | -58.39 | -9.63 | -749.93 | - | 34.43 |
Loss (Gain) From Sale of Investments | 560.66 | -49.07 | 1,670 | -321.86 | -298.74 |
Provision & Write-off of Bad Debts | 1,299 | -158.65 | 567.79 | 236.61 | -707.6 |
Other Operating Activities | 3,875 | 9,393 | 3,369 | 2,936 | -1,109 |
Change in Accounts Receivable | -28,109 | -6,540 | -10,317 | -1,664 | 3,990 |
Change in Inventory | 5,956 | -2,773 | -10,815 | -9,311 | -7,843 |
Change in Accounts Payable | 4,407 | 2,916 | 6,279 | 3,834 | 178.79 |
Change in Other Net Operating Assets | -2,566 | 730.77 | -2,061 | -5,326 | -3,910 |
Operating Cash Flow | 433.65 | 11,536 | -4,608 | -2,916 | -1,424 |
Operating Cash Flow Growth | -96.24% | - | - | - | - |
Capital Expenditures | -5,691 | -5,081 | -4,791 | -17,371 | -23,315 |
Sale of Property, Plant & Equipment | 101.91 | 27.3 | 3,578 | 55.92 | 3.72 |
Sale (Purchase) of Intangibles | - | - | - | -8.14 | -5,349 |
Investment in Securities | -2,943 | -2,374 | 4,200 | -1,214 | -1,731 |
Other Investing Activities | 134.2 | 30.52 | 397.4 | -250.64 | -31.22 |
Investing Cash Flow | -8,319 | -7,357 | 3,418 | -18,731 | -30,284 |
Short-Term Debt Issued | 25,877 | 18,000 | 10,500 | 6,100 | 10,000 |
Long-Term Debt Issued | - | 22,900 | - | 15,000 | 10,000 |
Total Debt Issued | 25,877 | 40,900 | 10,500 | 21,100 | 20,000 |
Short-Term Debt Repaid | -33,577 | -18,600 | -4,000 | -3,000 | -1,600 |
Long-Term Debt Repaid | -1,194 | -25,428 | -1,332 | -418.16 | -376.35 |
Total Debt Repaid | -34,771 | -44,028 | -5,332 | -3,418 | -1,976 |
Net Debt Issued (Repaid) | -8,894 | -3,128 | 5,168 | 17,682 | 18,024 |
Issuance of Common Stock | 18,540 | - | - | - | - |
Other Financing Activities | -2,111 | -2,072 | -1,935 | -1,169 | -259 |
Financing Cash Flow | 7,535 | -5,199 | 3,233 | 16,513 | 17,765 |
Foreign Exchange Rate Adjustments | -93.31 | - | - | -38.05 | 59.78 |
Net Cash Flow | -443.85 | -1,021 | 2,043 | -5,172 | -13,883 |
Free Cash Flow | -5,257 | 6,455 | -9,398 | -20,287 | -24,739 |
Free Cash Flow Margin | -4.03% | 4.90% | -7.82% | -18.92% | -24.10% |
Free Cash Flow Per Share | -166.97 | 230.04 | -8395.15 | -18122.49 | -22100.17 |
Cash Interest Paid | 1,374 | 2,072 | 1,935 | 1,169 | 259 |
Cash Income Tax Paid | 2,488 | 580.17 | 831.35 | 153.46 | 2,904 |
Levered Free Cash Flow | -6,736 | -3,248 | -16,751 | -30,438 | -28,800 |
Unlevered Free Cash Flow | -4,376 | 1,744 | -13,630 | -28,176 | -27,275 |
Change in Working Capital | -20,311 | -5,666 | -16,915 | -12,467 | -7,585 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.